Ethics & The 3Rs
The guiding framework for ethical research—Replace, Reduce, and Refine animal use through NAMs and human-relevant methods that benefit both science and welfare
Replace
Use non-animal methods whenever possible—prioritizing technologies that avoid animal use entirely.
- ✓ Organ-on-chip systems
- ✓ Human cell cultures and organoids
- ✓ Computer modeling (in silico)
- ✓ Human tissue samples
- ✓ Human volunteer studies
Reduce
Minimize the number of animals used to obtain information—using better experimental design and data sharing.
- ✓ Improved statistical methods
- ✓ Data sharing between labs
- ✓ Avoid unnecessary duplication
- ✓ Better experimental design
- ✓ Pilot studies before full experiments
Refine
Minimize suffering and improve welfare for animals that must still be used—better housing, handling, and procedures.
- ✓ Improved anesthesia protocols
- ✓ Humane endpoints
- ✓ Environmental enrichment
- ✓ Non-invasive monitoring
- ✓ Staff training in welfare
The Principles of Humane Experimental Technique
Russell and Burch publish their groundbreaking book proposing the 3Rs framework for ethical animal research.
EU Directive 86/609/EEC
European Union adopts legislation requiring consideration of alternatives to animal testing.
EU Directive 2010/63/EU
Updated EU legislation explicitly requires 3Rs implementation and prioritizes replacement methods.
FDA Modernization Act 2.0
US removes requirement for animal testing before human clinical trials, allowing NAMs as alternatives.
Why Better Science Means Better Ethics
The scientific case for human-relevant methods
Species Differences Cause Failures
90%+ of drugs that pass animal tests fail in human trials. Better human models mean better predictions and fewer wasted animal lives.
Human Cells = Human Answers
Using human cells provides directly relevant data, eliminating the need to extrapolate across species barriers.
Precision Medicine Requires Human Models
Patient-derived cells allow personalized treatment testing impossible with animal models.
Technology Enables Replacement
Organ chips, AI, and organoids now provide capabilities that didn't exist when animal models were established.
Regulatory Acceptance Growing
FDA, EMA, and other agencies increasingly accept NAMs data for regulatory decisions.
Economic Incentives Align
NAMs can be faster, cheaper, and more predictive—business case aligns with ethical imperative.
European Union
Directive 2010/63/EU mandates 3Rs, requires justification for animal use
United Kingdom
Animals (Scientific Procedures) Act requires 3Rs consideration
United States
FDA Modernization Act 2.0 removes animal testing requirement
Canada
CCAC guidelines require 3Rs implementation